April 2015

NCI Standard Funding Opportunity Announcements
Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates

NEW
Ongoing All Ranks Federal See BAA

Army Research Office Broad Agency Announcement (BAA) for Basic and Applied Scientific Research

The purpose of this BAA is to solicit research proposals in the engineering, physical, life, and information sciences for submission to the Army Research Office (ARO) for consideration for possible funding.
Due Dates: Up until March 31, 2017
Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals.
Amount & Project Period: No specific dollars have been reserved 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Links: ARO CORE BAA-W911NF-12-R-0012-Mod 03

Army Research Laboratory BAAs


NEW
April 06 SBCs Federal Tech Transfer

PHS 2014-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])

Small Business Concerns (SBCs) having research capabilities and technological expertise to contribute to R&D mission(s) of awarding components identified in FOA are encouraged to submit SBIR grant applications in response to identified topics.
Due Dates: Standard dates (Next April 06)
Amount & Project Period: Not to exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards
Not to exceed 1 year for Phase I and Not to exceed 2 years for Phase II
Eligibility: Small Business Concerns - primary employment of PD/PI must be w/SBC at time of award and during conduct of proposed project. For multiple PDs/PIs, at least one must meet primary employment requirement.
Contact: Christi Craig (x1458)
FOA Link: PA-14-071
NEW

PHS 2014-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])

Invites eligible U.S. small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) applications. U.S. SBCs having research capabilities and technological expertise to contribute to R&D mission(s) of NIH awarding components identified in FOA are encouraged to submit STTR grant applications in response to identified topics.
FOA Link: PA-14-072
NEW

Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44)

Development of next-generation tools distinguishing heterogeneous states among cells and having commercial potential. Applications should define current state of technology as benchmark against which new tool(s) will be measured. Should also propose proof-of-concept testing of tool(s) in a complex biological tissue or living organism
Amount & Project Period: Not to exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards
Not to exceed 2 years for Phase I and Not to exceed 3 years for Phase II
Eligibility: Small Business Concerns - primary employment of PD/PI must be w/SBC at time of award and during conduct of proposed project. For multiple PDs/PIs, at least one must meet primary employment requirement
FOA Link: PA-13-140
NEW

Direct Phase II SBIR Grants to Support Biomedical Technology Development

To encourage applications from eligible United States small business concerns (SBCs) demonstrating scientific and technical merit and feasibility of prototype stage of developing a biomedical technology that has commercial potential, R&D that is characteristic of Phase-I (R43) SBIR projects. Intended to facilitate SBIR-type R&D, to expand R&D opportunities for applicant small business concerns (SBCs), and to enhance pace of technology development and commercialization
Amount & Project Period: Not to exceed $1,000,000 - 2 years
FOA Link: PAR-14-088

NEW
April 08 (Pre-application) All Ranks Federal Breast Cancer

Congressionally Directed Medical Research Programs (CDMRP)

Breast Cancer Research Program (BCRP)
Breakthrough Award - Levels 1 & 2
W81XWH-15-BCRP-BREAKTHROUGH_FL12

Funding Level 1: Innovative, high-risk/high-reward research in the earliest stages of idea development. With potential to yield new avenues of investigation. Proof of concept. No preliminary data required.
Funding Level 2: Research already supported by preliminary data and has potential to make significant advancements toward clinical translation. Demonstration of efficacy in in vivo models, as applicable.
Partnering PI Option allows two PIs, termed Initiating and Partnering PIs, to collaborate on a single application.
Due Dates: April 08 (Pre-application) Ι April 20 (OSR) Ι April 22 (Sponsor)
Amount & Project Period: Level 1:  $375,000 (Direct Costs) - 3 years
Level 1 w/Partner PI: $600,000 (Direct Costs) - 3 years
Level 2:  $750,000 (Direct Costs) - 3 years
Level 2 w/Partner PI: $1.0M (Direct Costs) - 3 years
Eligibility: Investigators at all academic levels (or equivalent)
Postdocs are encouraged to apply under Levels 1 & 2
Clinical trials are not allowed for Levels 1 & 2
Contact: Linda Nolan (x6071)
PA Link: FY15 Breast Cancer Research Program (BCRP)
NEW

Breast Cancer Research Program (BCRP)

Era of Hope Scholar Award
W81XWH-15-BCRP-EOHS

Supports exceptionally talented, creative early-career scientists Application must address one or more of the overarching challenges related to the current breast cancer landscape.
Due Dates: April 08 (Letter of Intent) Ι April 20 (OSR) Ι April 22 (Sponsor)
Amount & Project Period: $2.5M (Direct Costs) - 5 years
Eligibility: Independent, non-mentored investigators w/in 6 years of last training position (e.g., postdoctoral fellowship, medical residency, clinical fellowship) as of application due date
PI must maintain a 50% commitment of full-time effort during award period to breast cancer research through a combination of this award and other current support.
Contact: Linda Nolan (x6071)
PA Link: FY15 Breast Cancer Research Program (BCRP)
U01 NCI

April 09 All Ranks Federal Cancer Care Delivery

Multilevel Interventions in Cancer Care Delivery: Building from the Problem of Follow-up to Abnormal Screening Tests

 1.    Seeks to advance the science of multilevel interventions in 3  ways:
          a) By establishing a common conceptualization of levels  & associated level-specific 
               factors that affect practice;
          b) By standardizing metrics of the levels and their main effects on other levels and the   
               individuals needing follow-up care;
          c) By developing and standardizing analysis of the effect of interventions on individuals, 
              groups, and organizations responsible for intervention implementation.
2.     Encourages applications that test interventions to improve the follow-up of abnormal
         screening in one or more ways, including:
          a) measuring multilevel effects of single-level interventions;
          b) comparing single vs. multilevel interventions;
          c) testing multilevel interventions
Due Dates: April 07 (OSR) Ι April 09 (Sponsor) Letter of Intent due 30 days prior to stated sponsor due date
Amount & Project Period: $450,000 to $500,000/year (Direct Costs) - 4 years
Eligibility: All Ranks
Contact: Linda Nolan, x6071
FOA Link: PAR-15-108


NEW
April 09 Jr Faculty Federal Career Development

Defense Advanced Research Projects Agency (DARPA)
Microsystems Technology Office  

Young Faculty Award (YFA)

Research Announcement (RA) solicits ground-breaking single-investigator proposals for research and development in 23 Technical Areas including:
Technical Area 09: Microbial Mediation of Host Tolerance to Infection - Specific topics may include, but aren’t limited to: symbiotic effects on innate and adaptive immune responses, exploration of host mechanisms distinguishing pathogens from commensals that could be leveraged for resilience, discovery and development of interventions that mimic microbial processes implicated in host resiliency, and -omics research to identify the differential host response to elucidate a microbial-induced state of tolerance
Technical Area 18:  Imaging, Communication, and Sensing through Highly Scattering Complex Media - Innovative experimental and theoretical research focused on optical transmission through highly scattering complex media. 

Applicants w/questions about specific topic areas can email DARPA-RA-15-23@darpa.mil with topic area stated in subject line. Your question will be distributed to the appropriate contact 
Due Dates: April 07 (OSR) Ι April 09 (Sponsor)
Amount & Project Period: $250,000/year - 2 years
Eligibility: Untenured Asst. /Assoc. Members w/in 5 years of appointment to tenure-track position
Contact: Linda Nolan (x6071)
RA Link: DARPA-RA-15-23
R44 NCI

NEW
April 13 (LOI) Al Ranks Federal SBIR Phase II Bridge

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics and Prognostics Toward Commercialization

Seeks applications from SBCs needing additional funding to support the next stage of development for projects that were previously funded under SBIR or STTR Phase II awards Projects must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices, and in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics.
Due Dates: April 13 (Letter of Intent) May 11 Ι (OSR) Ι May 13 (Sponsor)
Amount & Project Period: $1,000,000 (Total) - 3 years
Eligibility: Small Business Concerns (SBCs) - Phase IIB Competing Renewal (Phase IIB) Resubmission (only for Phase IIB applications previously submitted in response to RFA-CA-12-023 or RFA-CA-14-002
Contact: Christi Craig (x1458)
RFA Link: RFA-CA-15-010
 
April 14 All Faculty Non-federal Health Disparities

Robert Wood Johnson Foundation (RWJF)
Awards for Eliminating Health Disparities  

 Proposals sought to establish annual awards program honoring individuals who implement systems changes to solve health disparities. Program will span 7 years w/first winner selected in 2016. 10 organizations will be chosen to administer the awards programs Organizations must have experience with systems change in one or more of the following areas that influences health outcomes: access to quality health care, education, employment, income, community environment, housing or public safety.
Due Dates: April 10 (OSR) Ι April 14 (Sponsor)  
Applicant Web Conference March 25, 2015 (2 p.m. ET)
Register here.
Amount & Project Period: $60,000 (Total) - 7 years
Eligibility: All Faculty
Contact: Linda Nolan, x6071
Link: Overview


Spring Cycle 2015
April 15 Jr Faculty Non-federal Career Development

American Cancer Society Institutional Research Grant (ACS-IRG)
ACS-IRG Pilot Project Funding Opportunities

Pilot funding opportunities to support junior faculty in initiating cancer-related research projects that assist them in competing successfully for national research grants.
Due Dates: April 15 (4:00pm) to Maureen Ahearn
Amount & Project Period: $30,000 - 1 year
Eligibility: Full-time faculty members at Assistant Member/Assistant Professor level or equivalent are eligible
Must be w/in first 6 years of initial faculty appointment
May not have any active peer-reviewed funding at time of submission or award
Research Scientists are eligible to apply. Must be independent and within two years of a tenure-track appointment
Contact: Maureen Ahearn (x8824)
Links: ACS-IRG Application Ι ACS-IRG Guidelines


NEW
April 15 All Ranks Federal Vaccine Safety

FY15 Research, Monitoring and Outcomes Definitions for Vaccine Safety

This pilot program encourages collaborative efforts with experts across fields to maximize results and impact of research project. National Vaccine Program Office (NVPO) scientific staff will have substantial programmatic involvement above and beyond the normal stewardship role in awards.
Due Dates: April 13 (OSR) Ι April 15 (Sponsor)
Amount & Project Period: $250,000 (Total) - 1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Links: NV-VSR-15-001  Ι  FOA

NEW
April 16 All Ranks Non-Federal PCOR

Patient Centered Outcomes Research Institute  
Engagement Award (EAIN): Supporting Dissemination and Implementation Activities of the PCORI Pilot Projects Learning Network (PPPLN)

Support for dissemination and implementation activities for the PCORI Pilot Projects and the PCORI Pilot Projects Learning Network.
Due Dates: April 14 (OSR) Ι April 16 (Sponsor)
Amount & Project Period: $50,000 - 4 months
Eligibility: All Ranks
Contact: Scott Mears (x1397)
Links: Supporting Dissemination and Implementation Activities of the PCORI Pilot Projects Learning Network (PPPLN)  
Engagement Award Initiative Notice (EAIN)
R35 NIGMS
National Institute of General  Medical Sciences
April 20 (LOI) All Ranks Federal Research Support

Maximizing Investigators' Research Award (MIRA)

The MIRA is a grant to provide support for all of the research in an investigator's laboratory that falls within the mission of NIGMS. This FOA will test the feasibility of this grant mechanism through a pilot program with restricted eligibility
Due Dates: April 20 (Letter of Intent)
Applications:  May 18 (OSR) Ι May 20 (Sponsor)
Amount & Project Period: $750,000/year (Direct Costs) - 5 years
Eligibility: Targets investigators who received either >2 R01 equivalent awards or a single award of greater than $400,000 direct costs,  from NIGMS in FY2013 or 2014, and with support for >1 of their awards expiring in FY2016 or 2017.   Other investigators are ineligible.  Only single PD/PI applications are allowed PD/PIs must be able to devote 51% research effort to MIRA
Contact: Linda Nolan (x6071)
RFA Link: RFA-GM-16-002
Admin Supplements NIH

NEW
April 20 See Below Federal NIH-fundeded Biomedical Data Repositories

Supplements to Support Interoperability of NIH Funded Biomedical Data Repositories

Establish or improve interoperability among NIH funded biomedical data repositories. This is expected to lead to increased efficiency of repositories' operations and cost reductions, which are significant factors of the NIH's long-term sustainability plans for the biomedical data repositories
Due Dates: April 16 (OSR) Ι April 20 (Sponsor)
Amount & Project Period: $300,000 (Direct Costs) - 1 year
Eligibility: Parent award must be active and research proposed for supplement must be accomplished w/in competitive segment.
Proposed supplement must be to provide for an increase in costs due to unforeseen circumstances.
All additional costs must be w/in scope of peer reviewed and approved project.
Contact: Linda Nolan (x6071)
FOA Link: PA-15-144


April 21 Postdocs/Fellows Non-federal Career Development

Multiple Myeloma Research Foundation (MMRF)
Research Fellow Awards

To accelerate development of therapeutic approaches for myeloma; may include proposals in basic science, validation, or clinical research.
Due Dates: April 17 (OSR) Ι April 21 (Sponsor)
Amount & Project Period: $75,000 - 1 year
Eligibility: PhD, MD or equivalent degree at post-doctorate, clinical fellow or assistant professor levels and beginning studies in multiple myeloma field under supervision of a research mentor
Contact: Linda Nolan (x6071)
Links: MMRF Research Grants Ι 2015 Program Guidelines


NEW
April 21 (Pre-application) All Faculty Federal Bone Marrow Failure

Congressionally Directed Medical Research Programs (CDMRP) Bone Marrow Failure Research Program (BMFRP) Idea Development Award

Supports innovative ideas and high-impact approaches based on scientifically sound evidence in order to move towards the vision to understand and cure BMF. May include relevant preliminary data, but not required Clinical trials not supported.
Due Dates: April 21 (Pre-application)
Invited Submissions:  July 17 (OSR) Ι July 21 (Sponsor)
Amount & Project Period: $360,000 (direct costs) - 2 years
Eligibility: Established (EI) and Early Career Investigators (ECI)
EI should be at or above Associate Professor (or equivalent).
ECI should be independent investigator at Assistant Professor, Instructor, or Assistant Research Professor level and <10 years from terminal degree
Contact: Linda Nolan (x6071)
RFA Link: FY15 Bone Marrow Failure Research Program (BMFRP)

NEW
April 24 All Ranks Federal Regulatory Trng


U.S. Food and Drug Administration Commissioner Fellowship Program

For healthcare professionals, scientists, and engineers to receive regulatory science training and the chance to conduct cutting-edge research on targeted scientific, policy, or regulatory issues under the mentorship of an FDA senior scientist.
Due Dates April 22 (OSR) Ι April 24 (Sponsor)
Amount & Project Period: $1,000,000 (Total) - 3 years
Eligibility: Must have doctoral level degree
U.S. citizens, non-citizen nationals of the U.S., or have been admitted to U.S. for permanent residence when applications are submitted
Must have rec'd doctoral degree w/in 7 years of start date
Contact: Linda Nolan (x6071)
RFA Link: Fellowship Overview


NEW
April 24 (Pre-app) All Faculty Non-federal Drug Discovery

GlaxoSmithKline Discovery Partnerships with Academia (DPAc) Discovery Fast Track Challenge - North American Challenge

Looking for projects with a specific and testable hypothesis that would deliver therapeutic benefit to patients. Will undertake projects starting from early screening to late lead optimization and is open to a wide range of possibilities that have progressed beyond exploratory and technology platform stages.
Due Dates: April22 (OSR) Ι April 24 (Sponsor)
Eligibility: All Ranks - Academic partner has unique know-how and/or expertise essential to progress the target
Contact: Linda Nolan (x6071)
RFA Link: Discovery Fast Track Challenge


NEW
April 24 (Pre-application) All Ranks Federal Breast Camcer

Breast Cancer Research Program (BCRP)Breakthrough Award - Levels 3 & 4

Funding Level 3: Advanced translational studies w/potential for near-term clinical investigation. Small-scale clinical trials may apply.
Funding Level 4:  Large-scale projects to transform & revolutionize clinical management and/or prevent breast cancer. Near-term clinical impact is expected.
Partnering PI Option:  Allows 2 PIs, termed Initiating and Partnering, each of whom will each receive a separate award.
Due Dates: April 24 (Pre-application)
Invited Submissions:   July 24 (OSR) Ι July 28 (Sponsor)
Amount & Project Period: Level 3:  $2.5M (Direct Costs) - 5 years
Level 3 w/Partner PI: $2.5M (Direct Costs) - 5 years
Level 4:  $10M (Direct Costs) - 5 years
Level 4 w/Partner PI: $10M (Direct Costs) - 5 years
Eligibility: All academic levels (or equivalent). Note: An invited oral presentation is a requirement for application review of Funding Level 4 projects
Contact: Linda Nolan (x6071)
PA Link: FY15 Breast Cancer Research Program (BCRP)
NEW

Breast Cancer Research Program (BCRP)
Distinguished Investigator Award

Seeks new paradigms by supporting investigators who are proposing a fundamental shift or leap beyond existing track record of research. Does not support continuation of or incremental change from PI's published line of research. If not established breast cancer researcher, s/he must clearly articulate motivation and commitment for proposing a fundamental shift in research and must include at least 1 collaborator w/breast cancer expertise. Must include 2 or more breast cancer advocates on research team.
Due Dates April 24 (Pre-application)
Invited Submissions:  July 24 (OSR) Ι July 28 (Sponsor)
Amount & Project Period: $3.0M (direct costs) - 5 years
Eligibility: Assistant Professor or above (or equiv) >6 years after last mentored position as of application deadline
Contact: Linda Nolan (x6071)
PA Link: FY15 Breast Cancer Research Program (BCRP)


NEW
April 30 Jr Faculty Non-federal Research Development

Memorial Sloan Kettering Cancer Center (MSKCC) Paul Marks Prize for Cancer Research

Recognizes a new generation of leaders in cancer research making significant contributions to understanding of cancer or are improving treatment through basic or clinical research.
Due Dates: April 30 (Online Nomination Form)
Amount & Project Period: Up to 3 winners share cash award of $150,000 and present their work at a scientific symposium at Memorial Sloan Kettering Cancer Center  
Eligibility: Nominees must be age <45 on April 30, 2015
Contact: Linda Nolan (x6071)
Link: 2015 Call for Nominations


NEW
April 30 All Ranks Non-federal Career Development

Chest Foundation of the American College of Chest Physicians CHEST Diversity Committee Minority Investigator Research Grant

Supported in part by Astra Zenica
This award supports a clinical or translational project that contributes to the understanding of the pathophysiology or treatment of conditions or diseases related to pulmonary, cardiovascular, critical care, or sleep medicine.
Due Dates: April 28 (OSR) Ι April 30 (Sponsor)
Amount & Project Period: $25,000 - 1 year
Eligibility: American College of Chest Physicians membership required Special consideration for those w/in 5 years of completing advanced training program
Underrepresented Minority Investigator; African American, Latin American, Hispanic American, Asian/Pacific Island American, Native American, Women.
Contact: Linda Nolan (X6071)
Link: Apply for a Grant
NEW

CHEST Foundation and the Research Grant in Women's Lung Health
Supported in part by AstraZeneca

Programs and initiatives are focused in four key areas: clinical research grants, tobacco education and cessation, patient-focused public education, and community service grants.
Due Dates: April 28 (OSR) Ι April 30 (Sponsor)
Amount & Project Period: $10,000 - 1 year
Eligibility: American College of Chest Physicians membership required. Special consideration for those w/in 5 years of completing advanced training program
Contact: Linda Nolan (X6071)
Link: Apply for a Grant

Accelerating the world’s most promising research

NEW
April 30 All Faculty Non-federal Prostate Cancer

The Prostate Cancer Foundation

2015 Movember-PCF Challenge Awards for Metastatic, Lethal Prostate Cancer

Supports large-scale research projects concerning metastatic, lethal prostate cancer.
Awards dependent on level of innovation High risk, currently unfunded projects most desired.
Online application submission portal will go live
at https://pcf.smartsimple.com on March 24th.
Due Dates: April 28 (OSR) Ι April 30 (Sponsor)
Amount & Project Period: $1,000,000 (Total) - 2 year
Eligibility: At least 3 highly experienced investigators from one or several institutions.
Must embed at least 1 young investigator as integral contributor on team.
Young investigator shld/be w/in 6 years of completion of a professional degree or clinical training and have rec'd. no more than $200,000 in research support from all sources.
Contact: Linda Nolan (x6071)
Links: 2015 Request for Applications Ι Prostate Cancer Foundation 

Moffitt Medical Group
May 01 Jr Faculty Moffitt Career Development

MMG Junior Faculty Research Award

The MMG Junior Faculty Research Award (JFRA) is intended to ease transition to independence for investigators either in the laboratory or as clinical trialists.  Award promotes exploration of innovative ideas in translational research through the funding of pilot projects proposed by Moffitt investigators; will not support extensions of existing full projects.  The goal is to allow appropriate and motivated individuals to develop an independent research career in translational science focused on cancer.
Due Dates: May 01 (by 5:00pm)
Amount & Project Period: $50,000 - 1 year
Eligibility: Jr Faculty  at the Assistant and Associate member level
Contact: Lirieth Cruz  (X2557)
Links: MMG Junior Faculty Research Award Guidelines  Ι   Application


May 01 All Ranks Non-federal Cellular and Molecular Imaging in Cancer

Robarts Research Institute
2015 J. Allyn Taylor International Prize in Medicine

This prize is awarded annually to one or more individuals who have made significant contributions in basic or clinical research.  The 2015 Prize will be granted to a scientist who has made outstanding contributions in the area of Cellular and Molecular Imaging in Cancer.
Due Dates: May 01
Amount & Project Period: All Ranks
Eligibility: $25,000 - prize
Contact: Linda Nolan (x6071)
Link: Overview


NEW
May 01 (LOI) Postdocs Non-Federal Hematology

American Society of Hematology (ASH)
Scholar Award

Support for critical period required for completion of training and achievement of status as an independent investigator  See website for specific Basic/Translational and Clinical research areas for ASH.
Due Dates: May 01 (Letter of Intent)
Invited Applications:  July 30 (OSR) Ι August 03 (Sponsor)
Amount & Project Period: Fellow Scholars: $100,000 over a 2-3 year award
Jr. Faculty Scholars:  $150,000 over a 2-3 year award
Eligibility: As of LOI submission:
Fellows:  <5 years of resrch. experience after completion of PhD
MDs:       >3 but <5 years of resrch. experience
Jr. Faculty Scholar:  MD, PhD or MD/PhD applicants >5 but <10 years resrch. experience after completion of PhD

1. Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience.
2. All candidates required to be members of ASH in good standing for duration of program
Contact: Fellow Scholars: $100,000 over a 2-3 year award
Jr. Faculty Scholars:  $150,000 over a 2-3 year award
Link: Scholar Awards

NEW
May 01 (LOI) All Faculty Non-federal Drug Discovery

The Harrington Discovery Institute
University Hospitals Case Medical Center
Harrington Scholar-Innovator Program

The goal is to advance physician-scientist-initiated projects aimed at clinical introduction of new medicines (drugs or biologics). Specific focus of eligible projects includes fundamental discovery (elucidation of novel targets and leads) or development of novel drugs or biologics or drug-device combinations
Due Dates: May 01 (Letter of Intent)
Invited Applications:  July 30 (OSR) Ι August 03 (Sponsor)
Amount & Project Period: Up to $700,000 - 2 years ($100,000 guaranteed)
Eligibility: Must be a faculty physician-scientist, MD or MD/PhD
No multiple PIs allowed
Contact: Linda Nolan (x6071)
Link: Harrington Scholar-Innovator Grant
UH2 NIH

NEW
May 03 (LOI) All Ranks Federal BD2K

Big Data to Knowledge (BD2K) Advancing Biomedical Science Using Crowdsourcing and Interactive Digital Media

Supports development of new or significantly adapted interactive digital media that engage the public in performing some aspect of biomedical research via crowdsourcing. To be responsive, application is expected to pose a challenging biomedical research problem and propose development of engaging interactive digital media that incorporate crowdsourcing as a fundamental component of how the problem is solved.
Due Dates: May 03 (Letter of Intent) June 01 (OSR) Ι June 03 (Sponsor)
Amount & Project Period: Not to exceed $200,000/year (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-006

NEW
May 06 (Pre-app) All Faculty Federal Ovarian Cancer

Congressionally Directed Medical Research Programs (CDMRP) Deptartment of the Army - USAMRAA Ovarian Cancer Research Program (OCRP) 
Due Dates: May 06 (Pre-application)
Invited Submissions: August 03 (OSR) | August 05 (Sponsor)
Contact: Linda Nolan (x6071)


Pilot Award W81XWH-15-OCRP-PA

Supports innovative, high-risk/high-reward research that could ultimately lead to critical discoveries or major advancements that will drive ovarian cancer research forward Innovation and Impact are important review criteria Preliminary data are not required, but allowed Clinical trials are not allowed
Amount & Project Period: $250,000 (Direct Costs) - 2 years
Eligibility: Investigators at or above postdoc level (or equivalent)
Program Announcement Link: DoD Ovarian Cancer Pilot Award


Clinical Translational Award W81XWH-15-OCRP-CTA

Supports translational research addressing high-impact ideas in ovarian cancer
Supports pre-clinical and clinical research, and clinical trial-related research
Clinical trials are not allowed Can be used to support research projects related to/associated w/ongoing or completed clinical trials supported by other funding sources
Preliminary data are required
Amount & Project Period: $300,000 (direct costs) - 5 years
Eligibility: Independent investigator at or above Assistant Professor (or equiv) level
Program Announcement Link: DoD Ovarian Cancer Clinical Translational Award
Adm Supplement NCI

NEW
May 08 (LOI) All Ranks Federal Prevention/Control - LMICs

Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries

The NCI will provide administrative supplement awards to currently-funded P30 NCI-designated cancer center grantees to support pilot research plans that focus on cancer prevention and control
Due Dates: May 08 I Letter of Intent) Ι June 04 (OSR) Ι June 08 (Sponsor
Amount & Project Period: $260,000 (Direct Costs) - 2 years (At least 50% of proposed costs must be for the LMIC institution)
Eligibility: Parent award must be active and research proposed must be accomplished w/in currently approved project period. Period of supplement may not include any anticipated period of no-cost extension for the parent grant. Proposed research must be within original scope of NIH-supported grant.
Contact: Linda Nolan (x6071)
RFA Link: (PAR-15-155)
R01 NIH

May 12 All Ranks Federal Prevention-Native Americans

Interventions for Health Promotion and Disease prevention in Native American Populations

Develop, adapt, and test the effectiveness of health promotion and disease prevention interventions in Native American (NA) populations
Due Dates: May 10 (OSR) Ι May 12 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-14-260


NEW
May 13 (Pre-app) See Below Federal Career Development

Congressionally Directed Medical Research Programs (CDMRP) Dept. of the Army - USAMRAA Ovarian Cancer Research Program (OCRP)
Due Dates: May 13 (Pre-application)
Invited Submissions:  August 10 (OSR) Ι August 12 (Sponsor)       
Contact: Linda Nolan (x6071)

Ovarian Cancer Academy Early-Career Investigator W81XWH-15-OCRP-OCA

Early-Career Investigators for unique, interactive virtual academy that provides intensive mentoring, national networking, and a peer  group for junior faculty
Preliminary data are required.
Institutional match of $50,000 per year is required
Amount & Project Period: $725,000 (Direct Costs) - 5 years
Eligibility: Must be w/in first 3 years of first faculty appt. (or equiv) at submission (Tenure or non-tenure track).
Must commit no less than 25% effort to this award for first 2 years and have an overall 50% protected time for research
Program Announcement Link: DoD Ovarian Cancer Academy - Early-Career Investigator
Investigator-Initiated Research Award
W81XWH-15-OCRP-IIRA

Supports meritorious basic and clinically oriented research in  ovarian cancer with impact is an important review criterion. Preliminary data are required. Clinical trials are not allowed. Pilot awardees (past & present) are encouraged to apply.
Amount & Project Period: $450,000 (Direct Costs) - 3 years
Eligibility: Independent investigator at or above Assistant Professor (or equiv) level
Program Announcement Link: FY15 OCRP IIRA Program Announcement

May 15 (LOI) All Ranks Federal Conference Support

FY15 Announcement of the Anticipated Availability of Funds for Research Conferences on Research Integrity

Conferences or workshops must be designed to provide a forum for discussion and produce tangible outcomes related to at least one of the following themes:
     1) Responsible conduct of research training;
     2) Fostering an environment promoting research integrity;
     3) Prevention of research misconduct;
     4) Handling of research misconduct allegations;
     5) Whistleblowing;
     6) International issues in research integrity;
     7) Other topics linked to research integrity and compliance
Due Dates: May 13 (OSR) Ι May 15 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: IR-ORI-15-002
R01 NHLBI

NEW
May 15 (LOI) All Ranks Federal Lung Imaging

Molecular Imaging of the Lung - Phase 2

Supports studies that advance translation of identified probes and associated imaging approaches from animal models into applicability for human lung diseases Studies must include work performed in vivo using appropriate animal models of lung disease and studies using human tissues and/or cells. Applications proposing Investigational New Drug (IND)-enabling studies of novel probes and imaging approaches are encouraged.
Due Dates: May 15 (Letter of Intent) Ι  June 11 (OSR) Ι June 15 (Sponsor)
Amount & Project Period: $450,000/year (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-HL-16-001
R01 NIH
NCI is a participating institute
NEW
May 16 All Ranks Federal Obesity

Exploratory/Developmental Clinical Research Grants in Obesity

To conduct exploratory/developmental clinical studies accelerating development of effective interventions for prevention or treatment of overweight or obesity in adults and/or children. Exploratory epidemiological research with a goal of informing translational/clinical research will also be supported within this program.
Due Dates: Standard dates  Ι June 12 (OSR) Ι June 16 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: (PA-15-163)
U01 NIH

May 17 (LOI) All Faculty Federal Population Science & Cancer

Bridging the Gap Between Cancer Mechanism and Population Science

Any project that poses and addresses a challenging cancer question that can only be addressed by linking these two ends of the cancer spectrum - biological mechanism and population.
Due Dates: May 17 (Letter of Intent) (also Oct. 4th)
June 15 (OSR) Ι June 17 (Sponsor) (also Nov. 4th)
Amount & Project Period: $750,000/yr. (Direct Costs) - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
FOA Link: PAR-13-081
R21/R33 NCCIH
May 22 (LOI) All Ranks Federal Natural Product Testing

Phased Innovation Award for Exploratory Clinical Trials of Natural Products in NCCIH High Priority Research Topics

Supports pilot testing of natural products (i.e., botanicals, dietary supplements, and probiotics), having sufficient early-stage data to justify further clinical testing.  Intention is to speed translation of emerging basic science findings about natural products into clinical pilot testing to determine whether continued clinical research is warranted.
Due Dates: May 22 (Letter of Intent)
Applications:  June 18 (OSR) Ι June 22 (Sponsor)
Amount & Project Period: $275,000 (Total Direct Costs) - 2 years (R21)
$450,000 (Total Direct Costs) - 3 years (R33)
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-AT-16-001
P01 NIH

Annual Due Date
May 25 Al Faculty Federal Team Science

Program Project Grants and Center Grants (New, Renewal, Resubmission & Revision)

Program Project grants contain at least 3 component projects.  The individual projects may represent several disciplines and/or address several discrete research aspects pertinent to 1 or more disciplines. However, all of the projects must be relevant to the common unifying central theme, focus, and the overall objective of the entire program project. The individual projects should be clearly interrelated and synergistic so that the research ideas, efforts, and outcomes of the program as a whole will offer a distinct advantage over pursuing the individual projects separately.
Due Dates: May 21 (OSR) Ι May 25 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-023
R25 NCI

NEW
May 25 See Below Federal Cancer Education

NCI Cancer Education Programs

Due Dates: Standard dates Ι May 21 (OSR) Ι May 25 (Sponsor)
Contact: Linda Nolan (x6071)

Cancer Education Grants Program

To support innovative educational efforts that would help to reduce cancer incidence, morbidity, and mortality, and that would improve the quality of life of cancer patients.
Amount & Project Period: $300,000/year (Direct Costs) - 5 years
Eligibility: Established investigator in scientific area for which application is targeted, and capable of providing administrative and scientific leadership to development and implementation of proposed program.
FOA Link: PAR-12-049

Cancer Education Grants Program  Curriculum or Methods Development

This FOA will support creative educational activities with a primary focus on Curriculum or Methods Development. Applications that propose innovative, state-of-the-art programs, addressing the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients are encouraged.
Amount & Project Period: $100,000/year (Direct Costs) - 3 years
Eligibility: Established investigator at Associate Professor level or above in scientific area in which application is targeted, and capable of providing both administrative and scientific leadership to development and implementation of proposed program. An application that proposes to adapt a current or previously funded course to focus on a different target population is not considered to be new and innovative.
FOA Link: PAR-15-150


Cancer Education Grants Program - Courses for Skills Development

This FOA will support creative educational activities with a primary focus on Courses for Skills Development.   Applications that propose innovative, state-of-the-art programs, addressing the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients are encouraged.
Amount & Project Period: $300,000/year (Direct Costs) - 5 years
Eligibility: Established investigator at Associate Professor level or above in scientific area in which application is targeted, and capable of providing both administrative and scientific leadership to development and implementation of proposed program.  An application that proposes to adapt a current or previously funded course to focus on a different target population is not considered to be new and innovative.
FOA Link: PAR-15-151


Cancer Education Grants Program - Research Experiences

This FOA will support creative educational activities with a primary focus on Research Experiences. Applications that propose innovative, state-of-the-art programs, addressing the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients are encouraged.
Amount & Project Period: $300,000/year (Direct Costs) - 5 years
Eligibility: Established investigator at Associate Professor level or above in scientific area in which application is targeted, and capable of providing both administrative and scientific leadership to development and implementation of proposed program.
FOA Link: PAR-15-152


NEW
May 26 (LOI) All HOPA Members Non-federal Hemtology Oncology

The Hematology/Oncology Pharmacy Association (HOPA) Foundation 2015 HOPA Research Fund Award

To support a hematology/oncology pharmacy practice research project with subsequent publication. Pharmacy practice is broadly defined including areas such as outcomes, surveys, patient safety, standards validation, and translational science applications. Multiple institutions may be involved in the project, and co-PI projects are allowed.
Due Dates: May 26 (Letter of Intent)
Invited Apps:  Sept. 03 (OSR) Ι Sept. 07 (Sponsor)
Amount & Project Period: $50,000 - 1 year
Eligibility: Open to all HOPA members
Contact: Linda Nolan (x6071)
RFA Link: 2015 HOPA Research Fund Award

&
Exp. May 28
Int. June 03		 All Ranks Federal Healthcare Research

National Science Foundation & National Institutes of Health Smart and Connected Health (SCH)

The goal of this interagency program is development of next generation health and healthcare research through high-risk, high-reward advances in understanding of and applications in information science, technology, behavior, cognition, sensors, robotics, bio-imaging, and engineering. Collaboration between academic, industry, non-profit and other organizations is strongly encouraged to establish better linkages between fundamental science, clinical practice and technology development, deployment and use.
Due Dates: Exploratory:  May 26 (OSR) Ι May 28 (Sponsor)
Integrative:   June 1 (OSR) Ι June 03 (Sponsor)
Amount & Project Period: Exploratory: $170,000/year (Direct Costs) - 3 years
Integrative:  $370,000/year (Direct Costs) - 4 years
Eligibility: All Ranks - An investigator may participate as PI, co-PI, Project Director, Senior Personnel or Consultant in no more than two proposals submitted in response to this solicitation.
Contact: Linda Nolan (x6071)
FOA Link: NSF-13-543
R01 NIH
National Center for Complementary  and Integrative Health       

       
May 29 (LOI) All Ranks Federal Natural Product Testing

Exploratory Clinical Trials and Studies of Natural Products in NCCIH High Priority Research Topics

Support provided to confirm link between impact of natural product on biological signature (i.e., mechanism of action) and demonstrate an association between change in the biological signature and clinical outcomes. Intention is to speed translation of emerging basic science findings about natural products into clinical pilot testing to determine whether continued clinical research is warranted.
Due Dates: May 29 (Letter of Intent)
Applications:  June 25 (OSR) Ι June 29 (Sponsor)
Amount & Project Period: $450,000 (Total Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-AT-16-002




May 29 All Ranks Non-federal Drug Discovery

Sanford Ι Burnham Medical Research Institute
Florida Translational Research Program
2015 Spring Call for Submissions

Concept or assay development projects for use in pre-therapeutic discovery via high-throughput screening - development of innovative biochemical and cell-based assays for biological targets, pathways, or processes for which there are limited selective and potent small molecule modulators available
High-throughput screening (HTS)-ready assays - well-developed, HTS-ready assays suitable for high-throughput screening of the Sanford-Burnham library of compounds for the purpose of identifying small-molecule modulators of the target, pathways, or processes of interest Validated hits for the discovery of pre-therapeutic lead compounds - proposals that aim to further research and development of existing small-molecule chemical scaffolds for use in vivo
Due Dates: May 27 (OSR) Ι May 29 (Sponsor)
Amount & Project Period: No funding - 1 year
Provides access to technological resources for drug development facilitating an interdisciplinary, collaborative approach to the establishment of a pipeline of potential new treatments for today's most challenging and unmet medical needs.
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Link: Florida Translational Research Program at Sanford-Burnham
S10 NIH

May 29 All Ranks Federal Equipment

Shared Instrumentation Grant (SIG) Program

Encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems. Types of instruments supported include: X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters, and biomedical imagers.
Due Dates: May 27 (OSR) Ι May 29 (Sponsor)
Amount & Project Period: Maximum: $600,000 - 1 year
Eligibility: PD/PI should have documented technical expertise directly related to chosen instrument.
Major User group of 3 or more individuals must be identified. Each must be a PD/PI on a distinct NIH award with one of the following activity codes: R01, DP1, DP2, P01, P50, R37, and U01. Major Users must have substantial interests in and needs for the instrument.
Major Users can be researchers from the same department or from several departments, divisions or schools at applicant institution, or from nearby or regional institutions.
Contact: Christi Craig (x1458)
FOA Link: PAR-15-088
R01 NCI

NEW
May 29 (LOI) All Ranks Federal Provocative Questions

Research Answers to NCI's Provocative Questions

Supports research projects designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions initiative Intended to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have not received sufficient attention.
Due Dates: May 29 (Letter of Intent) Ι June 25 (OSR) Ι June 29 (Sponsor)
Sept 20 (Letter of Intent) Ι Oct 27(OSR Ι Oct 29 (Sposnor)
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-008
R21 NCI

NEW
May 29 (LOI) All Ranks Federal Provocative Questions

Research Answers to NCI's Provocative Questions

Supports research projects designed to solve specific problems and paradoxes in cancer research identified by the NCI Provocative Questions initiative Intended to challenge cancer researchers to think about and elucidate specific problems in key areas of cancer research that are deemed important but have not received sufficient attention.
Due Dates: May 29 (Letter of Intent) | June 25 (OSR)│June 29 (Sponsor)
Sept 20 (Letter of Intent)  | Oct 27(OSR)│Oct 29 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-009


NEW
June 01 All Faculty Federal Health Disparities

Ponce School of Medicine-Moffitt Cancer Center (PSM-MCC) Partnership Research Project Funding Opportunity Cancer Health Disparities

The Ponce School of Medicine-Moffitt Cancer Center (PSM-MCC) Partnership invites faculty investigators to apply for funds to develop a grant application featuring multiple PIs with a goal of developing a competitive extramural proposal to address cancer health disparities.  Proposals must be in one of the PSM-MCC Partnership target areas: Cancer Research, Cancer Training, and Cancer Outreach.
Due Dates: Monday, June 1, 2015 by 4:00 pm (Submit as 1 email attachment to Sabrina Rodriguez at sabrina.rodriguez@moffitt.org or Hannia Delgado at hdegaldo@psm.edu
Amount & Project Period: Full Projects:  $125,000/institution ($250,000 Total) 
Pilot Projects: $62,500/ institution   ($125,000 Total)
Term is 2 years
Eligibility: Only ranked faculty members are eligible
Must be a partnership between a faculty member from PSM and a faculty member from Moffitt.
Submit 1 joint application w/2 PIs
Faculty members limited to 1 application submission as PI, but may be listed as collaborators on additional applications.
Contact: Sabrina Rodriguez (x6565)
Links: Click here for Guidelines Ι Click here for Application


June 01 All Ranks Non-federal Pediatric Brain Cancer

The Cure Starts Now Foundation Research Grants

Funds search for a cure for brainstem glioma and other forms of pediatric brain cancer in the hopes of curing all cancers Focus is on Diffuse Intrinsic Brainstem Glioma (DIPG), and to support translational and clinical research projects in those areas.
Due Dates: May 28 (OSR) Ι June 01 (Sponsor) (Hardcopy by June 5th)
Amount & Project Period: $100,000 - 1 year
Eligibility: All Ranks
Contact: Shaina Sine (x3658)
Link: Research & Grants

NEW
June 01 All Faculty Moffitt Neuro-Oncology, Sarcoma or
Adolescent & Young Adults (AYA)

Chotiner Pediatric Research Pilot Funding Opportunity

Moffitt Leadership is pleased to announce a pilot funding opportunity focused on Pediatric Cancer with preference given to proposals in Neuro-Oncology, Sarcoma or a focus on Adolescent & Young Adults (AYA). 
Due Dates: Monday, June 01 at 4:00 pm. Please submit proposal and biosketch to Maureen Ahearn
Amount & Project Period: up to $50,000 for 12 months
Eligibility: All Faculty Ranks (Assistant, Associate and Senior Members )
Contact: Maureen Ahearn (X8824)
Links: Chotiner Pediatric Guidelines  Ι  Chotiner Pediatric Face Page

NEW
June 03 Jr Faculty Non-federal Prostate

Prevent Cancer Foundation
2015 PCF Young Investigator Awards

Applicants may be working in basic, translational, or clinical research; need not be trained specifically in prostate cancer research. However, successful applicants should be working in a research environment capable of supporting transformational prostate cancer research. Access to and interaction with a clinical environment, as well as translational prostate cancer physician-scientists, is highly desirable.
Due Dates: June 01 (OSR) Ι June 03 (by 3:pm (EDT) Sponsor))
The online application submission portal will go live at https://pcf.smartsimple.com on Friday, April 17, 2015.   Please direct questions to applications@pcf.org
Amount & Project Period: $75,000/year - 3 years
Eligibility: Should be w/in 6 years of completing a professional degree or clinical training such as MD, PhD, DSc, MD-PhD or equivalent and hold the title of Senior Postdoctoral Fellow, Instructor, Research Associate, Assistant Professor, or equivalent. Must be under direct supervision of a mentor. Applicants should have received no more than $200,000 in current direct research funding from all sources including institutional funds.
Contact: Linda Nolan (x6071)
RFA Link: Request for Applications  Ι  Prevent Cancer Foundation
R01/U01 NIH

Cycle II Due Date for new submissions
June 05 All Ranks Federal Research Support

Research Grants and Cooperative Agreements 

An R01 is used to support a discrete, specified, circumscribed research project with no specific dollar amount unless specified in the FOA (advance permission required for direct costs of $500K or more in any year).  These are usually awarded for 3-5 years.  A U01 is similar with the exception that there is substantial programmatic involvement from the Awarding Institute and Center.
Due Dates: June 03 (OSR) Ι June 05 (Sponsor)
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All ranks, unless otherwise specified
Contact: Linda Nolan (x6071)
R01 NCI

NEW
June 05 All Ranks Federal Early Life Factors & Cancer

Early-life Factors and Cancer Development Later in Life

Research focused on role of early-life factors in cancer development later in life. It is necessary to better understand 1) Early-life (maternal-paternal, in utero, birth and infancy, puberty and adolescence, and teenage and young adult years) factors associated with later cancer development; 2) How early-life factors mediate biological processes relevant to carcinogenesis; and 3) Whether predictive markers for cancer risk based on what happens biologically at early-life can be measured and developed for use in cancer prevention strategies.
Due Dates: Standard dates  June 03 (OSR) Ι June 05 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: (PA-15-126)  
R01 NIAID

National Institute of Allergies & Infectious Diseases

NEW
June 05 All Ranks Federal Immunodeficiency

Investigations on Primary Immunodeficiency Diseases

Supports innovative investigations in primary immunodeficiency diseases. Of particular interest are detection of primary immunodeficiency diseases, identification of molecular basis, and design and pre-clinical development of innovative therapies for these diseases.
Due Dates: Standard dates June 03 (OSR) Ι June 05 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: PAR-15-130  
R01 NIH

NEW
June 05 All Ranks Federal Probiotic/Prebiotic & Human Microbiome

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research

NCI plans to support rigorous translational and clinical studies to promote cancer prevention and treatment and to understand the molecular processes (including how pro/prebiotics compete with pathogens, increase the production of protective metabolites and reduce the production of pro-carcinogens, etc.) with the aim to determine how a person's risk of developing cancer or cancer treatment outcomes can be modified by pro/prebiotics.
Due Dates: Standard dates June 03 (OSR) Ι June 05 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PA-15-127
U01 NIH

NEW
June 08 (LOI) All Ranks Federal Cancer Epidemiology Cohorts (CECs)

Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts

Applications for targeted infrastructure support of core functions of Cancer Epidemiology Cohorts (CECs) and methodological research.  NCI will support infrastructure and core functions for existing or new CECs, and will also lead to support of core functions for CECs currently funded through other grant mechanisms by the Epidemiology and Genomics Research Program (EGRP) and other components of the Division of Cancer Control and Population Sciences (DCCPS) at NCI.
Due Dates: June 08 (Letter of Intent)
Applications:  July 06 (OSR) Ι July 08 (Sponsor)
Amount & Project Period: Direct Costs for any year not to exceed $2.5M - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-104
R01 NIH

Cycle II Due Date for new submissions
June 12 All Ranks Federal Career Development

K-Series

Awards for candidates who wish to further develop their careers in biomedical, behavioral an clinical research. Applicants are generally required to hold a research or health - professional doctoral degree or its equivalent; eligibility for some Career Development Awards is limited to only applicants with health professional doctoral degrees.
Due Dates: June 10 (OSR) Ι June 12 (Sponsor)
Amount & Project Period: Funding varies depending on type of K-Award and Institute or Center, usually includes salary support and some funds for research.  Duration is up to 5 years
Eligibility: Dependent on Type of K-award
Contact: Linda Nolan (x6071)
Link: Information about NIH Career Development Awards
R21/R03 NCI

NEW
June 16 All Ranks Federal Early Life factors & Cancer

Early-life Factors and Cancer Development Later in Life

Research focused on role of early-life factors in cancer development later in life.  It is necessary to better understand 1) Early-life (maternal-paternal, in utero, birth and infancy, puberty and adolescence, and teenage and young adult years) factors associated with later cancer development; 2) How early-life factors mediate biological processes relevant to carcinogenesis; and 3) Whether predictive markers for cancer risk based on what happens biologically at early-life can be measured and developed for use in cancer prevention strategies.
Due Dates: Standard dates  June 12 (OSR) Ι June 16 (Sponsor)
Amount & Project Period: R21:  $275,000 (Direct Costs) - 2 years
R03:  $100,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Links: R21: PA-15-125  Ι R03:  PA-15-124  


NEW
June 16 All Ranks Federal Healthcare

Agency for Healthcare Research and Quality
AHRQ Small Research Grant Program (R03)

AHRQ's specific priority areas of focus are:
1) Improve health care quality by accelerating implementation of Patient Centered Outcomes 
2) Research (PCOR)
3) Make health care safer
4) Increase accessibility by evaluating expansions of insurance coverage
5) Improve health care affordability, efficiency and cost transparency
Due Dates: Standard dates Ι June 12 (OSR) Ι June 16 (Sponsor)
Amount & Project Period: $100,000 (Total Costs) - 2 years
Eligibility: All Ranks - Only 1 PD/PI allowed on application
Contact: Linda Nolan (x6071)
FOA Link: PA-15-147
R21 NIH

NEW
June 16 All Ranks Federal Digestive Diseases and Nutrition

Pilot and Feasibility Clinical Research Studies in Digestive Diseases and Nutrition

Encourages pilot and feasibility clinical and epidemiological research studies of new therapies or means of health promotion and prevention of digestive and liver diseases and nutritional disorders associated with digestive and liver diseases.
Due Dates: Standard dates Ι June 12 (OSR) Ι June 16 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PA-12-139  
R03 - R21 NIH

Cycle II Due Date for new submissions
June 16 All Ranks Federal Research Support

Other Research Grants

The Small Grant Program (R03) Provides limited funding for a short period of time to support a variety of types of projects, including: pilot or feasibility studies, collection of preliminary data, secondary analysis of existing data, small, self-contained research projects, development of new research technology, etc.

The Exploratory/Developmental Research Grant Award (R21) encourages new, exploratory and developmental research projects by providing support for the early stages of project development. Sometimes used for pilot and feasibility studies.
Due Dates: June 12 (OSR) Ι June 16 (Sponsor)
Amount & Project Period: R03:  $100,000 (Total Direct Costs - 2 years
R21:  $275,000 (Total Direct Costs - 2 years
Eligibility: All Ranks, unless otherwise specified
Contact: Linda Nolan (x6071)
R21 NIH

NEW FOA #
June 17 All Ranks Federal Health Disparities

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities

Basic research studies into the biological/genetic causes and mechanisms of cancer health disparities.
Due Dates: June 15 (OSR) Ι June 17 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-092
R01 NIH

NEW FOA #
June 17 All Ranks federal Health Disparities

Basic Cancer Research in Cancer Health Disparities

To investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention intervention strategies, (2) development & testing of new methodologies & models, and (3) secondary data analyses
Due Dates: June 15 (OSR) Ι June 17 (Sponsor)
Amount & Project Period: $250,000 (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
PAR Link: PAR-15-093
R21 NIH


NEW FOA #
June 22 All Ranks Federal Career Development

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research

Supports eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences workforce. Provides a bridge to investigators that have completed their research training and may need extra time to develop a larger research project grant application.
Due Dates: June 18 (OSR) Ι June 22 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-053

\
June 30 All Ranks Non-federal Leukemia

Children's Leukemia Research Association, Inc.
Research Grants

Funds the most promising studies to isolate the causes of leukemia.
Due Dates: June 26 (OSR) Ι June 30 (Sponsor)
Amount & Project Period: $30,000 - 1 year
Eligibility: All Ranks
Contact: Linda Nolan  (x6071)
Link: Research Grants


NEW
July 01 Postdocs Non-federal Career Development

Helen Hay Whitney Foundation Research Fellowship

Grants financial support of sufficient duration to help further the careers of young men and women engaged in basic biological or medical research.
Due Dates: June 29 (OSR) Ι July 01 (Sponsor)
Amount & Project Period: Yr 01:  $51,000 (Stipend) - $1,500 (Allowance)
Yr 02:  $52,000 (Stipend) - $1,500 (Allowance)
Yr 03:  $53,000 (Stipend) - $1,500  (Allowance)
Eligibility: Hold, or be in final stages of obtaining PhD, MD, or equivalent
Have < 1 year of postdoctoral research experience as of due date and who have received a PhD < 2 years before due date, or MD degree < 3 years before due date.
Contact: Linda Nolan (x6071)
RFA Link: Research Fellowships

NEW
July 01 All Ranks Non-federal Lung

Lung Cancer Research Foundation 2014 Research Grants

Medical/scientific research projects covering all aspects of lung cancer research Grants are awarded for lung cancer projects focused on one or more of the following:
1) Basic science
2) Translational research
3) Clinical research
4) Supportive care
5) Quality of care/outcomes
   
Due Dates: June 29 (OSR) Ι July 01 (Sponsor)
Amount & Project Period: $75,000 - 1 year
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Link: 2015 Research Grants

July 01 Jr. Faculty Non-federal Career Development

Damon Runyon Cancer Research Institute Innovation Award

To provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding.
Due Dates: June 29 (OSR) Ι July 01 (Sponsor) by 4:00pm ET
Amount & Project Period: $150,000/year - 2 years (with opportunity for up to 2 additional years)
Eligibility: Applicants must belong to one of the following:
Tenure-track Assistant Professors w/in first 4 years of initial Assistant Professor position (Cut-off date: July 1, 2011.)
Clinical Instructors and Senior Clinical Fellows (in final year of sub-specialty training) holding an MD and pursuing a period of independent research before a tenure-track faculty position. 
Applicants are expected to commit a minimum of 80% FTE to conducting research.
Contact: Linda Nolan (x6071)
Links: Overview  Ι  Application Guidelines
R01/U01 NIH

July 05 All Ranks Federal Research Projects

Research Grants and Cooperative Agreements

An R01 is used to support a discrete, specified, circumscribed research project with no specific dollar amount unless specified in the FOA (advance permission required for direct costs of $500K or more in any year).  These are usually awarded for 3-5 years.  A U01 is similar with the exception that there is substantial programmatic involvement from the Awarding Institute and Center.
Due Dates: Standard Due Dates Ι July 02 (OSR) Ι July 05 (Sponsor)
Amount & Project Period: Budgets not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PA-13-302 (Current Parent) plus other various Announcements
R01 NIDDK

NEW
July 05 (LOI) All Faculty Ranks Federal Hematology

New Directions in Hematology Research (SHINE-II)

Investigator-initiated grant applications are invited for basic or pre-clinical, proof of principle research projects that are tightly focused and directed at validating novel concepts and approaches that promise to open up new pathways for discovery.
Due Dates: July 05 (Pre-application)
Applications:  August 03rd (OSR) Ι August 5th (Sponsor)
Amount & Project Period: $200,000/year (Direct Costs) - 3 years
Eligibility: All Faculty Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAS-15-168
R01 NCCIH
National Center for Complementary and Integrative Health
July 05 (LOI See Below Federal STTR-Chemistry

Methods Development in Natural Products Chemistry

Small Business Technology Transfer (STTR) grant applications are sought from small business concerns (SBCs) to address problems associated with the methods of collection, bioassay, isolation, purification, de-replication, yield, and supply that hamper the full utilization of natural products.
Due Dates: July 05 (Letter of Intent)
Applications:  August 03rd (OSR│August 5th/5:00 PM (Sponsor)
Amount & Project Period: Total may not exceed $150,000 for Phase I awards - 6 month performance period
Eligibility: Only United States small business concerns (SBCs) are eligible to submit applications
Contact: Christi Craig (x1458)
RFA Link: RFA-AT-16-004  
K-series NIH

July 12 All Ranks Federal Career Development

Research Career Development Awards

Awards for candidates who wish to further develop their careers in biomedical, behavioral an clinical research. Applicants are generally required to hold a research or health - professional doctoral degree or its equivalent; eligibility for some Career Development Awards is limited to only applicants with health professional doctoral degrees.
Due Dates: Standard Due Dates Ι July 09 (OSR) Ι July 12 (Sponsor)
Amount & Project Period: Funding varies depending on type of K-Award and Institute or Center, usually includes salary support and some funds for research.  Duration is up to 5 years
Eligibility: Dependent on type of CDA sought
Contact: Linda Nolan (x6071)
FOA Link: Information about NIH Career Development Awards
R03/R21 NIH


REMINDER
July 16 All Ranks Federal Research Projects

Other Research Grants

The Small Grant Program (R03) Provides limited funding for a short period of time to support a variety of types of projects, including: pilot or feasibility studies, collection of preliminary data, secondary analysis of existing data, small, self-contained research projects, development of new research technology, etc.
 
The Exploratory/Developmental Research Grant Award (R21) encourages new, exploratory and developmental research projects by providing support for the early stages of project development. Sometimes used for pilot and feasibility studies
Due Dates Standard Due Dates Ι July 14 (OSR) Ι July 16 (Sponsor)
Amount & Project Period: R03:  $100,000 (Total Direct Costs - 2 years
R21:  $275,000 (Total Direct Costs - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)


NEW
July 31 All Faculty Non-federal Cutaneous Lymphoma

Cutaneous Lymphoma Foundation (CLF) Research Awards Program (RAP) 2015 CLARIONS Grant

Funds innovative research in all areas of cutaneous lymphomas with particular interest in:
• Etiology and risk factors of cutaneous lymphomas 
• Measures of disease impact on individuals & populations affected
• Translating discoveries into diagnostic and therapeutic advances in cutaneous lymphomas
• Optimizing therapies for cutaneous lymphomas
Due Dates: July 29(OSR) Ι July 31 (Sponsor)
Amount & Project Period: $25,000 (Total) - 1 year (renewable)
Eligibility: Investigators at all levels
Medical students and graduate students are not eligible
Contact: Linda Nolan (x6071)
Links: CLARIONS Grant Application  Ι  Research Awards Program
Toolboxstrong>
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org